Credo Pharma Private Limited, a active private limited company, was established on 23 July 2013 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232TG2013PTC089087. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.50 Cr and a paid-up capital of ₹1.13 Cr.
It upholds a compliant status. Its leadership includes Aluru Narmada (Director), Kandru Madhavarao (Director), Siva Rama Prasad Aluru (Director). Past directors included Aluru Narmada, Kandru Madhavarao, Siva Rama Prasad Aluru. It holds no open charges and ₹3.10 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No:102 Aditya Trade Centre, Ameerpet, Hyderabad, Telangana, 500038.
U24232TG2013PTC089087
089087
23 July 2013
₹4.50 Cr
₹1.13 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Credo Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aluru Narmada | Director | 24 Mar 2014 | Current |
| Kandru Madhavarao | Director | 23 Jul 2013 | Current |
| Siva Rama Prasad Aluru | Director | 01 Jul 2019 | Current |
| Aluru Vamsi Krishna | Director | 23 Jul 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Dec 2014 | Past |
| Pramod Abcsdd | Whole-Time Director | 05 Oct 2018 | Past |
| Pramod Abcsdd | Additional Director | 21 Dec 2020 | Past |
| Pramod Abcsdd | Director | 30 Mar 2015 | Past |
| Pramod Abcsdd | Whole-Time Director | 05 Oct 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Credo Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 130.22% increase. The company also saw a substantial improvement in profitability, with a 61% increase in profit. The company's net worth dipped by a decrease of 6.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Credo Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹31,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2014 | Hdfc Bank Limited | ₹3.10 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Credo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Credo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Credo Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Credo Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Credo Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Siva Rama Prasad Aluru was appointed as a Director was appointed as a Director on 01 Jul 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.
Progress on A charge registered on 27 Jun 2014 via Charge ID 10515731 with Hdfc Bank Limited was fully satisfied on 06 Jun 2017. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 3.10 Cr with Charge ID 10515731 was registered on 27 Jun 2014. was completed.
Progress on Aluru Narmada was appointed as a Director was appointed as a Director on 24 Mar 2014 & has been associated with this company since 11 years 8 months . was documented.
The CIN of Credo Pharma Private Limited is U24232TG2013PTC089087.
Credo Pharma Private Limited is headquartered at Flat No:102 Aditya Trade Centre, Ameerpet, Hyderabad, Telangana, 500038.
Credo Pharma Private Limited was incorporated on 23 July 2013.
The current directors of Credo Pharma Private Limited are
The primary industry of Credo Pharma Private Limited is Trade.
Credo Pharma Private Limited is unlisted.
The authorized capital of Credo Pharma Private Limited is ₹4.50 Cr, and the paid-up capital is ₹1.13 Cr.
The compliance status of Credo Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX